@Athenis so we can expect a CRL and a resubmittal process for another year? This will put us in a bad spot as the Eversana deal will be terminated within 6 months without approval.
@No_mercy I had only noticed that Steven Lo used exactly the same words in the informarion about our DRL as the CEO of Evoke at his DRL. Same 1:1. have a look: